Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · SEI

MetLife Small Company Equity Fund Investor Shares (MSVVX)

Ticker MSVVX · · Holdings as of Jun 30, 2026

Expense ratio
1.24%$124/yr per $10k
5-yr return
+10.7%annualized
1-yr return
+8.7%as of Dec 2025
Net assets
$7.9Mall share classes
Holdings
78

Bottom line

Is MSVVX a good fund? The bottom line

MSVVX is the Investor share class of MetLife Small Company Equity Fund, an actively managed small-cap mutual fund from SEI.

It charges 1.24% — about $124 a year on every $10,000 invested, more expensive than 74% of small-cap funds we track.

It returned +8.7% over one year, +10.7% a year over five years (as of Dec 31, 2025, per its prospectus).

With $7.9 million in net assets and 78 holdings, its largest position is N/a (3.7%) and the top 10 make up 19.7% of the portfolio.

What stands out

  • 5-year return beat 88% of category peers

What to watch

  • Expensive for its category (1.24%)
  • 12b-1 marketing fee of 0.25% a year
  • Small fund ($7.9 million) — small funds are likelier to close

Updated Nov 19, 2026

What MSVVX invests in

The MetLife Small Company Equity Fund (the Small Company Equity Fund or the Fund) seeks to provide long-term capital appreciation with less volatility than the U.S. small company market.

Under normal circumstances, the Fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small companies. This investment policy may be changed by the Fund upon 60 days prior written notice to shareholders. For purposes of the Funds 80% policy, equity securities include common stocks and exchange-traded funds (ETFs) with economic characteristics similar to equity securities. The Fund considers small companies to be those with market capitalizations within the range of the market capitalizations of companies in the Russell 2500 Index at the time of purchase, and ETFs that aim to replicate or produce returns that generally correspond to small company indexes. The market capitalization range of the Russell 2500 Index was approximately $24 million to $32.5 billion as of September 30, 2025, and may change over time. At any given time…

From the fund's prospectus (filed Jan 28, 2026).

MSVVX performance

Average annual total returns
1 yr5 yr10 yr
MSVVX+8.7%+10.7%—
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full MSVVX performance history →

What MSVVX costs

On a $10,000 investment, MSVVX's 1.24% expense ratio costs about $124 a year. The prospectus estimates $3,368 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full MSVVX fee table →

MSVVX top 10 holdings

#Holding% of fund
1N/a3.67%
2Halozyme Therapeutics, Inc.1.99%
3Kontoor Brands, Inc.1.99%
4SPDR Series Trust - SPDR S&P Biotech ETF1.88%
5Advanced Energy Industries, Inc.1.85%
6Praxis Precision Medicines Inc1.75%
7iShares Russell 2000 ETF1.72%
8Zions Bancorporation, National Association1.66%
9Gates Industrial Corporation Plc1.64%
10Standardaero, Inc.1.60%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 19.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to MSVVX

More funds like MSVVX →

MSVVX FAQ

What is the expense ratio of MSVVX?
MSVVX's expense ratio is 1.24%, which works out to about $124 a year for every $10,000 invested. The prospectus estimates total costs of $3,368 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MSVVX a good investment?
It depends on your goals, but the data points to: 5-year return beat 88% of category peers; expensive for its category (1.24%); 12b-1 marketing fee of 0.25% a year; small fund ($7.9 million) — small funds are likelier to close. This is general information, not personalized advice.
What does MSVVX hold?
MSVVX's largest holdings are N/a (3.7%), Halozyme Therapeutics, Inc. (2.0%), Kontoor Brands, Inc. (2.0%), SPDR Series Trust - SPDR S&P Biotech ETF (1.9%), Advanced Energy Industries, Inc. (1.9%). It holds 78 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is MSVVX's 5-year return?
MSVVX returned +10.7% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Who manages MSVVX?
MSVVX is offered by SEI through Advisors' Inner Circle Fund III.